THIS DOCUMENT BELONGS TO TESTBANKSPROF
Complete Test Bank Lilleys Pharmacology For Canadian Health Care
Practice 4th Edition
By Sealock
Al Chapters (1-58) |Q&A Verified Answers with Rationales| Graded A+
ISBN 9780323694803
~1~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
TABLE OF CONTENTS
Chapter 01: Nursing Practice in Canada and Drug Therapy ................................. 4
Chapter 02: Pharmacological Principles ............................................................... 8
Chapter 03: Legal and Ethical Considerations ..................................................... 13
Chapter 04: Patient-Focused Considerations ...................................................... 18
Chapter 05: Gene Therapy and Pharmacogenomics ........................................... 26
Chapter 07: Patient Education and Drug Therapy .............................................. 34
Chapter 08: Over-the-Counter Drugs and Natural Health Products ................... 38
Chapter 09: Vitamins and Minerals ..................................................................... 42
Chapter 10: Principles of Drug Administration................................................... 46
Chapter 11: Analgesic Drugs ................................................................................ 56
Chapter 12: General and Local Anaesthetics ....................................................... 63
Chapter 13: Central Nervous System Depressants and Muscle Relaxants Sealock:
.............................................................................................................................. 68
Chapter 14: Central Nervous System Stimulants and Related Drugs .................. 73
Chapter 15: Antiepileptic Drugs .......................................................................... 78
Chapter 16: Antiparkinsonian Drugs .................................................................. 83
Chapter 17: Psychotherapeutic Drugs ................................................................. 88
Chapter 18: Substance Misuse ............................................................................. 95
Chapter 19: Adrenergic Drugs ........................................................................... 101
Chapter 20: Adrenergic-Blocking Drugs............................................................ 107
Chapter 21: Cholinergic Drugs ........................................................................... 112
Chapter 22: Cholinergic-Blocking Drugs ........................................................... 117
Chapter 23: Antihypertensive Drugs ................................................................. 121
Chapter 24: Antianginal Drugs .......................................................................... 127
Chapter 25: Heart Failure Drugs ........................................................................ 133
Chapter 26: Antidysrhythmic Drugs .................................................................. 139
Chapter 27: Coagulation Modifier Drugs ........................................................... 143
Chapter 28: Antilipemic Drugs .......................................................................... 148
Chapter 29: Diuretic Drugs ................................................................................ 155
Chapter 30: Fluids and Electrolytes ................................................................... 160
Chapter 31: Pituitary Drugs ............................................................................... 165
~2~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 32: Thyroid and Antithyroid Drugs...................................................... 170
Chapter 33: Antidiabetic Drugs ......................................................................... 176
Chapter 34: Adrenal Drugs ................................................................................ 183
Chapter 35: Women’s Health Drugs ................................................................... 187
Chapter 36: Men’s Health Drugs ........................................................................ 194
Chapter 37: Antihistamines, Decongestants, Antitussives, and Expectorants
Sealock: .............................................................................................................. 200
Chapter 38: Respiratory Drugs .......................................................................... 204
Chapter 39: Acid-Controlling Drugs................................................................... 209
Chapter 40: Antidiarrheal Drugs and Laxatives ................................................ 214
Chapter 41: Antiemetic and Antinausea Drugs ................................................. 220
Chapter 42: Nutritional Supplements................................................................ 224
Chapter 43: Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins,
Macrolides, and Tetracyclines ........................................................................... 228
Chapter 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other
Drugs .................................................................................................................. 233
Chapter 45: Antiviral Drugs ............................................................................... 237
Chapter 46: Antitubercular Drugs ..................................................................... 243
Chapter 47: Antifungal Drugs ............................................................................ 248
Chapter 48: Antimalarial, Antiprotozoal, and Anthelmintic Drugs .................. 254
Chapter 49: Anti-inflammatory and Antigout Drugs ......................................... 258
Chapter 50: Immunosuppressant Drugs ........................................................... 263
Chapter 51: Immunizing Drugs and Pandemic Preparedness .......................... 267
Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–
Specific Drugs ..................................................................................................... 271
Chapter 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and
Miscellaneous Drugs .......................................................................................... 276
Chapter 54: Biological Response–Modifying Drugs and Antirheumatic Drugs 279
Chapter 55: Anemia Drugs ................................................................................. 284
Chapter 56: Dermatological Drugs .................................................................... 288
Chapter 57: Ophthalmic Drugs .......................................................................... 293
Chapter 58: Otic Drugs ....................................................................................... 297
~3~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
CORRECT ANSWER: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement
is made about how a patient responds to heath conditions and life processes or
vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the
patient is unable to swallow, he cannot take medication orally, as ordered. The nurse
needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
CORRECT ANSWER: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the
route with the prescriber. This is not a “right time” problem because the ordered
frequency has not changed. This is not a “right dose” problem because the dose is not
related to an inability to swallow. This is not a “right medication” problem because the
medication ordered will not change, just the route.
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen
since the first dose and has been documenting signs of possible adverse effects. What
nursing process phase is the nurse practising?
a. Planning
~4~
Complete Test Bank Lilleys Pharmacology For Canadian Health Care
Practice 4th Edition
By Sealock
Al Chapters (1-58) |Q&A Verified Answers with Rationales| Graded A+
ISBN 9780323694803
~1~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
TABLE OF CONTENTS
Chapter 01: Nursing Practice in Canada and Drug Therapy ................................. 4
Chapter 02: Pharmacological Principles ............................................................... 8
Chapter 03: Legal and Ethical Considerations ..................................................... 13
Chapter 04: Patient-Focused Considerations ...................................................... 18
Chapter 05: Gene Therapy and Pharmacogenomics ........................................... 26
Chapter 07: Patient Education and Drug Therapy .............................................. 34
Chapter 08: Over-the-Counter Drugs and Natural Health Products ................... 38
Chapter 09: Vitamins and Minerals ..................................................................... 42
Chapter 10: Principles of Drug Administration................................................... 46
Chapter 11: Analgesic Drugs ................................................................................ 56
Chapter 12: General and Local Anaesthetics ....................................................... 63
Chapter 13: Central Nervous System Depressants and Muscle Relaxants Sealock:
.............................................................................................................................. 68
Chapter 14: Central Nervous System Stimulants and Related Drugs .................. 73
Chapter 15: Antiepileptic Drugs .......................................................................... 78
Chapter 16: Antiparkinsonian Drugs .................................................................. 83
Chapter 17: Psychotherapeutic Drugs ................................................................. 88
Chapter 18: Substance Misuse ............................................................................. 95
Chapter 19: Adrenergic Drugs ........................................................................... 101
Chapter 20: Adrenergic-Blocking Drugs............................................................ 107
Chapter 21: Cholinergic Drugs ........................................................................... 112
Chapter 22: Cholinergic-Blocking Drugs ........................................................... 117
Chapter 23: Antihypertensive Drugs ................................................................. 121
Chapter 24: Antianginal Drugs .......................................................................... 127
Chapter 25: Heart Failure Drugs ........................................................................ 133
Chapter 26: Antidysrhythmic Drugs .................................................................. 139
Chapter 27: Coagulation Modifier Drugs ........................................................... 143
Chapter 28: Antilipemic Drugs .......................................................................... 148
Chapter 29: Diuretic Drugs ................................................................................ 155
Chapter 30: Fluids and Electrolytes ................................................................... 160
Chapter 31: Pituitary Drugs ............................................................................... 165
~2~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 32: Thyroid and Antithyroid Drugs...................................................... 170
Chapter 33: Antidiabetic Drugs ......................................................................... 176
Chapter 34: Adrenal Drugs ................................................................................ 183
Chapter 35: Women’s Health Drugs ................................................................... 187
Chapter 36: Men’s Health Drugs ........................................................................ 194
Chapter 37: Antihistamines, Decongestants, Antitussives, and Expectorants
Sealock: .............................................................................................................. 200
Chapter 38: Respiratory Drugs .......................................................................... 204
Chapter 39: Acid-Controlling Drugs................................................................... 209
Chapter 40: Antidiarrheal Drugs and Laxatives ................................................ 214
Chapter 41: Antiemetic and Antinausea Drugs ................................................. 220
Chapter 42: Nutritional Supplements................................................................ 224
Chapter 43: Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins,
Macrolides, and Tetracyclines ........................................................................... 228
Chapter 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other
Drugs .................................................................................................................. 233
Chapter 45: Antiviral Drugs ............................................................................... 237
Chapter 46: Antitubercular Drugs ..................................................................... 243
Chapter 47: Antifungal Drugs ............................................................................ 248
Chapter 48: Antimalarial, Antiprotozoal, and Anthelmintic Drugs .................. 254
Chapter 49: Anti-inflammatory and Antigout Drugs ......................................... 258
Chapter 50: Immunosuppressant Drugs ........................................................... 263
Chapter 51: Immunizing Drugs and Pandemic Preparedness .......................... 267
Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–
Specific Drugs ..................................................................................................... 271
Chapter 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and
Miscellaneous Drugs .......................................................................................... 276
Chapter 54: Biological Response–Modifying Drugs and Antirheumatic Drugs 279
Chapter 55: Anemia Drugs ................................................................................. 284
Chapter 56: Dermatological Drugs .................................................................... 288
Chapter 57: Ophthalmic Drugs .......................................................................... 293
Chapter 58: Otic Drugs ....................................................................................... 297
~3~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
CORRECT ANSWER: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement
is made about how a patient responds to heath conditions and life processes or
vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the
patient is unable to swallow, he cannot take medication orally, as ordered. The nurse
needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
CORRECT ANSWER: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the
route with the prescriber. This is not a “right time” problem because the ordered
frequency has not changed. This is not a “right dose” problem because the dose is not
related to an inability to swallow. This is not a “right medication” problem because the
medication ordered will not change, just the route.
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen
since the first dose and has been documenting signs of possible adverse effects. What
nursing process phase is the nurse practising?
a. Planning
~4~
